Syndax Pharmaceuticals (SNDX) Treasury Shares (2015 - 2025)

Syndax Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.6 million for Q4 2025.

• On a quarterly basis, Treasury Shares rose 100.72% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 100.72% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 100.72% from the prior year.
• Treasury Shares grew to $2.6 million in Q4 2025 per SNDX's latest filing, from $1.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.6 million in Q4 2025 and bottomed at $132333.0 in Q4 2021.
• The 5-year median for Treasury Shares is $392288.0 (2023), against an average of $634897.7.
• Across the five-year window, Treasury Shares soared 615.31% in 2021 and surged 52.89% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $132333.0 in 2021, then surged by 69.87% to $224788.0 in 2022, then jumped by 131.08% to $519436.0 in 2023, then soared by 151.06% to $1.3 million in 2024, then soared by 100.72% to $2.6 million in 2025.
• Per Business Quant, the three latest SNDX Treasury Shares figures stand at $2.6 million (Q4 2025), $1.3 million (Q4 2024), and $519436.0 (Q4 2023).